Nitrated-fatty Acids Modulation of Type Ii Diabetes
Nitro oleic acid and related metabolites are agonists of PPAR-?. Surprisingly, nitro oleic acid is a more potent agonist of PPAR-?, relative to nitro linoleic acid. Thus, nitro oleic acid and its metabolites, as well as their pharmaceutically acceptable salts and prodrug forms, are candidate therapeutics for the treatment of type-2 diabetes, which results from insulin resistance accompanying the improper functioning of PPAR-?.
Attached files:Patents:WO 2,009,017,802
Inventor(s):
FREEMAN BRUCE A [US]
Type of Offer:
Licensing
« More Medical Patents